VOLU SOL INC
8-K, 2000-05-03
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: MEMORIAL FUNDS, DEF 14A, 2000-05-03
Next: SUMMIT BROKERAGE SERVICES INC / FL, 10SB12G/A, 2000-05-03




<PAGE>

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K


                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


                           Date of Report: May 3, 2000



                                 VOLU-SOL, INC.
             (Exact name of registrant as specified in its charter)



                         Commission File Number: 0-23153

         Utah                                      87-0543981
(State of Incorporation)            (I.R.S. Employer Identification No.)


     5095 West 2100 South
     Salt Lake City, Utah                            84120
(Address of principal executive offices)          (Zip Code)


       Registrant's telephone number, including area code: (801) 974-9474





<PAGE>



ITEM 5. OTHER EVENTS

On April 11, 2000, the board of directors of the Registrant  announced a reverse
split of its Common Stock issued and outstanding,  to become effective April 28,
2000.  The action  reduces  the number of issued and  outstanding  shares of the
Registrant's Common Stock at a ratio of 1 for 5. Prior to the reverse split, the
Registrant  had a  total  of  12,221,092  shares  of  Common  Stock  issued  and
outstanding.  After  giving  effect to the reverse  split,  there are  2,444,219
shares of Common Stock issued and outstanding.

The reverse split as adopted by the Company's board of directors did not require
a change in the par value of the Company's Common Stock. Therefore,  both before
and after the reverse  split,  the par value of the  Company's  Common  Stock is
$.0001 per share.  In  addition,  the Board of  Directors  has not  authorized a
change in the authorized  number of shares of Common Stock or any other class of
securities of the Company.  Therefore,  both before and after the reverse split,
the authorized  number of shares of Common Stock would continue to be 50,000,000
shares.

Outstanding  options,  warrants and preferred stock  convertible to Common Stock
will be  adjusted  according  to the terms of the  instruments  evidencing  such
rights  and  shares,  reducing  the  number of shares  that may be  acquired  by
exercise  or  conversion,  as the  case may be,  by the  same 1 for 5 ratio  and
increasing  the  exercise  price in the case of the options and  warrants,  by 5
times the  current  price.  No other  rights or  interests  are  affected by the
change.

The  board of  directors  determined  that  the  reverse  split  was in the best
interest of the Registrant to enable the  Registrant to attract more  investment
capital and to prepare the Registrant for the trading of its common stock on the
OTC Bulletin Board.

























                                   Page 2 of 3


<PAGE>



                                    SIGNATURE

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant has duly caused this report,  as amended,  to be signed on its behalf
by the undersigned thereunto duly authorized.

                                    VOLU-SOL, INC.
                                    (Registrant)


                                    By: /s/ Michael G. Acton
                                    -------------------------------
Date: May 3, 2000                   Michael G. Acton
                                    Acting Chief Financial Officer








































                                   Page 3 of 3




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission